Benzbromarone
Benzbromarone is a uricosuric medication primarily used in the treatment of gout and hyperuricemia. It works by increasing the excretion of uric acid in the urine, thereby lowering the levels of uric acid in the blood.
Mechanism of Action[edit | edit source]
Benzbromarone inhibits the reabsorption of uric acid in the proximal tubule of the kidney. This action is achieved by blocking the URAT1 transporter, which is responsible for the reabsorption of uric acid from the urine back into the blood. By inhibiting this transporter, benzbromarone increases the excretion of uric acid, reducing its concentration in the blood and helping to prevent the formation of uric acid crystals in the joints.
Indications[edit | edit source]
Benzbromarone is indicated for the treatment of:
Dosage and Administration[edit | edit source]
The dosage of benzbromarone varies depending on the severity of the condition and the patient's response to the medication. It is typically administered orally, with doses ranging from 50 mg to 200 mg per day. The medication should be taken with food to minimize gastrointestinal side effects.
Side Effects[edit | edit source]
Common side effects of benzbromarone include:
- Gastrointestinal disturbances (e.g., nausea, vomiting, diarrhea)
- Rash
- Liver enzyme abnormalities
Serious side effects, although rare, may include:
- Hepatotoxicity
- Severe allergic reactions
Contraindications[edit | edit source]
Benzbromarone is contraindicated in patients with:
- Severe liver disease
- Kidney stones
- Hypersensitivity to benzbromarone or any of its components
Drug Interactions[edit | edit source]
Benzbromarone may interact with other medications, including:
- Warfarin: Increased risk of bleeding
- Azathioprine: Increased risk of toxicity
- Other uricosuric agents: Potential additive effects
History[edit | edit source]
Benzbromarone was first introduced in the 1970s and has been used in various countries for the management of gout and hyperuricemia. However, its use has been limited in some regions due to concerns about hepatotoxicity.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Translate: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD